Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021011345 - CRYSTALLINE LORLATINIB : FUMARIC ACID AND SOLID STATE FORM THEREOF

Publication Number WO/2021/011345
Publication Date 21.01.2021
International Application No. PCT/US2020/041524
International Filing Date 10.07.2020
IPC
C07D 498/18 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
498Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
12in which the condensed system contains three hetero rings
18Bridged systems
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 498/18
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
498Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
12in which the condensed system contains three hetero rings
18Bridged systems
Applicants
  • PLIVA HRVATSKA D.O.O [HR]/[HR]
  • TEVA PHARMACEUTICALS USA, INC. [US]/[US] (BB)
Inventors
  • KORDIC, Lorena
  • GREBENAR, Ivica
  • ŠAMEC, Dijana Škalec
Agents
  • BREW, Michael R.
  • DELUCA, Peter
  • MEAGHER, Edward C.
Priority Data
62/875,60118.07.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) CRYSTALLINE LORLATINIB : FUMARIC ACID AND SOLID STATE FORM THEREOF
(FR) LORLATINIB CRISTALLIN : ACIDE FUMARIQUE ET FORMES À L'ÉTAT SOLIDE CORRESPONDANTES
Abstract
(EN)
The present disclosure relates to crystalline Lorlatinib : Fumaric acid, solid state forms thereof, processes for preparation thereof, pharmaceutical compositions and methods of use thereof.
(FR)
La présente invention concerne du lorlatinib cristallin : acide fumarique, des formes à l'état solide correspondantes, des procédés de préparation, des compositions pharmaceutiques et des procédés d'utilisation associés.
Latest bibliographic data on file with the International Bureau